"Early days hype-driven capital was wasted. It was not well allocated," Emily Paxhia, the founding and managing partner of Poseidon Investment Management said at the recent Benzinga Cannabis Capital Conference in Miami.
Societal CDMO Inc. (NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for small molecule therapeutics, reported financial results for the three and six months ended June 30, 2023.
In a resounding stand, the Council of Trustees of the Shinnecock Nation Tribe responded directly to remarks made during TILT Holdings (OTC: TLLTF)'s recent 2Q earnings call. The call from the tribe is clear: the group is resolute and unbowed.
Psychedelics biotech giant COMPASS Pathways (NASDAQ: CMPS) has entered into a securities purchase agreement for an initial $125 million and potential additional of $160 million, with a select group of healthcare specialist investors.
Cannabis company Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) reported its financial and operating results on Wednesday for the second quarter ended June 30, 2023, revealing a 2% sequential increase and 9.3% year-over-year drop in revenue
Cannabis company Halo Collective Inc. (NEO: HALO) (OTCPK: HCANF) (FSE: A9K0) reported Tuesday its financial results for the second quarter of 2023 revealing revenue of $3.57 million down by 48.1% lower than in the same period of 2022.